drugset / Trial / NCT02629003
[11C]Cimbi-36 Dosimetry
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this study is to determine the dosimetry for the Positron Emission Tomography (PET) tracer \[11C\]Cimbi-36 in two different Carbon-11 labelling positions. This information will contribute to determining whether \[11C\]Cimbi-36 can be optimized by changing the C-11 labelling position.
Timeline
- Start
- 2015-12
- Primary completion
- 2018-10-10
- Completion
- 2018-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | [11C]Cimbi-36 | Diagnostic / imaging agent | 1.5 ug | Intravenous |
| Comparator | [11C]Cimbi-36 | Diagnostic / imaging agent | 600 mbq | Intravenous |
| Comparator | [11C]Cimbi-36-5 | Diagnostic / imaging agent | 1.5 ug | Intravenous |
| Comparator | [11C]Cimbi-36-5 | Diagnostic / imaging agent | 600 mbq | Intravenous |
Indications
No indication recorded.